84 related articles for article (PubMed ID: 12685813)
1. Dual ambroxal and chlorpheniramine resinate as an alternative carrier in concurrent resinate administration.
Akkaramongkolporn P; Ngawhirunpat T
Pharmazie; 2003 Mar; 58(3):195-9. PubMed ID: 12685813
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release.
Huang RG; Schwartz JB; Ofner CM
Pharm Dev Technol; 1999 Jan; 4(1):107-15. PubMed ID: 10027219
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro release of dual-drug resinate complexes containing codeine and chlorpheniramine.
Zeng HX; Wang M; Jia F; Lin SJ; Cheng G; Pan WS
Drug Dev Ind Pharm; 2011 Feb; 37(2):201-7. PubMed ID: 20653463
[TBL] [Abstract][Full Text] [Related]
4. Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs.
Zeng HX; Cheng G; Pan WS; Zhong GP; Huang M
Drug Dev Ind Pharm; 2007 Jun; 33(6):649-65. PubMed ID: 17613029
[TBL] [Abstract][Full Text] [Related]
5. Molecular state of chlorpheniramine in resinates.
Akkaramongkolporn P; Yonemochi E; Terada K
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):231-4. PubMed ID: 10705510
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of differently sulfonated styrene-divinylbenzene cross-linked copolymer cationic exchange resins as novel carriers for drug delivery.
Akkaramongkolporn P; Ngawhirunpat T; Opanasopit P
AAPS PharmSciTech; 2009; 10(2):641-8. PubMed ID: 19452281
[TBL] [Abstract][Full Text] [Related]
7. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins.
Yewale CP; Rathi MN; Kore GG; Jadhav GV; Wagh MP
Pharm Dev Technol; 2013; 18(2):367-76. PubMed ID: 22023351
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine.
Akkaramongkolporn P; Kulvanich P; Pathipvanich M
Drug Dev Ind Pharm; 2006 Apr; 32(4):483-96. PubMed ID: 16638687
[TBL] [Abstract][Full Text] [Related]
9. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex.
Halder A; Maiti S; Sa B
Int J Pharm; 2005 Sep; 302(1-2):84-94. PubMed ID: 16102927
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus.
Attama AA; Nkemnele MO
Int J Pharm; 2005 Nov; 304(1-2):4-10. PubMed ID: 16198521
[TBL] [Abstract][Full Text] [Related]
11. Development and physicochemical characterization of clindamycin resinate for taste masking in pediatrics.
Daihom B; Alayoubi A; Ma D; Wang L; Mishra S; Helms R; Almoazen H
Drug Dev Ind Pharm; 2016 Oct; 42(10):1600-8. PubMed ID: 26928944
[TBL] [Abstract][Full Text] [Related]
12. Drug-polymer combinations. Part 1: The preparation of sustained release drugs by combination with ion exchanging resins.
Gyselinck P; van Severen R; Braeckman P; Schacht E
Pharmazie; 1981 Nov; 36(11):769-72. PubMed ID: 7323125
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of propranolol hydrochloride based on ion-exchange resin entrapped within polystyrene microcapsules.
Halder A; Sa B
J Microencapsul; 2006 Dec; 23(8):899-911. PubMed ID: 17390631
[TBL] [Abstract][Full Text] [Related]
14. Ion-exchange resins as drug delivery carriers.
Guo X; Chang RK; Hussain MA
J Pharm Sci; 2009 Nov; 98(11):3886-902. PubMed ID: 19226637
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of oral controlled release chlorpheniramine-ion exchange resinate suspension.
Kadam AU; Sakarkar DM; Kawtikwar PS
Indian J Pharm Sci; 2008; 70(4):531-4. PubMed ID: 20046790
[TBL] [Abstract][Full Text] [Related]
16. Complexation using direct current: novel batch method for drug-resinate preparation.
Jumde AB; Umekar MJ; Kotagale NR
Drug Dev Ind Pharm; 2013 Jul; 39(7):978-84. PubMed ID: 22656264
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Chloroquine Resinate Feasibility and In Vitro Taste Masking Evaluation for Pediatric Formulations.
Guimarães TF; Vital ICF; de Sousa EGR; Boniatti J; Bandini TB; Carr O; Oliveira ON; Shimizu FM; da Fonseca LB; Viçosa AL
AAPS PharmSciTech; 2022 Feb; 23(2):69. PubMed ID: 35112208
[TBL] [Abstract][Full Text] [Related]
18. [Investigations in Bioavailability of resinates as peroral retard drug dosage forms. Part 1: Pharmaceutical availability of dihydrocodein-resinates (author's transl)].
Mühlenbruch B; Strauss H; Glaubitz H
Pharmazie; 1982 Mar; 37(3):200-3. PubMed ID: 7100242
[TBL] [Abstract][Full Text] [Related]
19. Effect of polysulfonate resins and direct compression fillers on multiple-unit sustained-release dextromethorphan resinate tablets.
Pongjanyakul T; Priprem A; Chitropas P; Puttipipatkhachorn S
AAPS PharmSciTech; 2005 Sep; 6(2):E190-7. PubMed ID: 16353977
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
